You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 3, March 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Surgical Cytokines
 •Oncology, Other
 •Hepatobiliary Surgery
 •Alert me on articles by topic

Safety Limit of Large-Volume Hepatic Radiofrequency Ablation in a Rat Model

Kelvin K. Ng, PhD; Chi Ming Lam, MS; Ronnie T. Poon, MS; Tony W. Shek, MBBS; David W. Ho, MPhil; Sheung Tat Fan, MS, MD, PhD

Arch Surg. 2006;141:252-258.

Background  Large-volume hepatic radiofrequency ablation (RFA) has been used to treat large liver tumors, but its safety limit is unknown. This study aimed to investigate the possible systemic responses of large-volume hepatic RFA and to estimate its safety limit in normal and cirrhotic rats.

Hypothesis  Large-volume hepatic RFA causes a significant systemic inflammatory reaction.

Design  Experimental study.

Setting  University teaching hospital.

Intervention  Using the Cool-tip RF System (Radionics, Burlington, Mass), RFA was performed for different percentages of the liver volume by weight in normal and cirrhotic Sprague-Dawley rats.

Main Outcome Measures  Changes in concentrations of serum inflammatory markers (tumor necrosis factor {alpha} [TNF-{alpha}] and interleukin [IL] 6), functions of various end organs, and survival rates were assessed.

Results  In the normal liver groups, the concentrations of TNF-{alpha} and IL-6 were significantly elevated in the early postoperative period when 50% (mean ± SD TNF-{alpha} concentration, 130.3 ± 15.6 pg/mL; mean ± SD IL-6 concentration, 163.2 ± 12.2 pg/mL) and 60% (mean ± SD TNF-{alpha} concentration, 145.7 ± 13.0 pg/mL; mean ± SD IL-6 concentration, 180.8 ± 11.0 pg/mL) of the liver volume were ablated compared with the control group (mean ± SD TNF-{alpha} concentration, 30.4 ± 9.9 pg/mL, P<.001; mean ± SD IL-6 concentration, 28.4 ± 6.7 pg/mL, P<.001). The concentrations of TNF-{alpha} and IL-6 in other groups remained similar to those in the control group. Thrombocytopenia, prolonged clotting time, and interstitial pneumonitis occurred when 50% and 60% of the liver volume were ablated. The 4-week survival rates were 100%, 60%, and 0% when 40%, 50%, and 60%, respectively, of the liver volume were ablated. Similar systemic inflammatory responses and poor survival rates were observed among the cirrhotic liver groups when 30% and 40% of the liver volume were ablated.

Conclusions  The normal rats can tolerate RFA of 40% of the liver volume with minimal morbidity and no mortality whereas the cirrhotic rats can only tolerate 20% of the ablated liver volume. Beyond that limit, RFA would cause significant systemic inflammatory responses and poor survival.


Author Affiliations: Centre for the Study of Liver Disease (Drs Ng, Lam, Poon, Shek, and Fan and Mr Ho) and Departments of Surgery (Drs Ng, Lam, and Poon and Mr Ho) and Pathology (Dr Shek), University of Hong Kong, Pokfulam, Hong Kong.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.